Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIG1 | P18858 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29849984 | 0.78 | ESR1 (0.51) | LIG1POLBMEN1KMT2AESR1 | |
| SCHEMBL22215860 | 0.78 | ESR1 (0.51) | LIG1POLBMEN1KMT2AESR1 | |
| SCHEMBL10631908 | 0.76 | BRD4 (0.61) | LIG1BRD4POLBMEN1KMT2A | |
| SCHEMBL30428722 | 0.76 | BRD4 (0.61) | LIG1BRD4POLBMEN1KMT2A | |
| SCHEMBL22550192 | 0.76 | MAPT (0.47) | LIG1POLBMEN1KMT2AESR1 | |
| SCHEMBL29850026 | 0.76 | MAPT (0.47) | LIG1POLBMEN1KMT2AESR1 | |
| SCHEMBL22550189 | 0.76 | ESR1 (0.57) | POLBMEN1KMT2ACYP1A2CYP2C9 | |
| SCHEMBL23517480 | 0.75 | MAPT (0.40) | MEN1KMT2AESR1ESR2GAA | |
| SCHEMBL15814552 | 0.75 | MAPT (0.40) | MEN1KMT2AESR1ESR2GAA | |
| SCHEMBL29849850 | 0.75 | MAPT (0.40) | MEN1KMT2AESR1ESR2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10981865-B2 | Substituted or unsubstituted allyl group-containing maleimide compound, production method therefor, and composition and cured product using said compound | DIC CORPORATION (JP) | 2021-04-20 | — | — | US | disclosed |
| US-20200325101-A1 | SUBSTITUTED OR UNSUBSTITUTED ALLYL GROUP-CONTAINING MALEIMIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND COMPOSITION AND CURED PRODUCT USING SAID COMPOUND | DIC CORPORATION (JP) | 2020-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10981865-B2 | Substituted or unsubstituted allyl group-containing maleimide compound, production method therefor, and composition and cured product using said compound | BMI1, WEE1, WEE2 | LIG1 1836/4885BRD4 88/4885POLB 2718/4885 |
| US-20200325101-A1 | SUBSTITUTED OR UNSUBSTITUTED ALLYL GROUP-CONTAINING MALEIMIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND COMPOSITION AND CURED PRODUCT USING SAID COMPOUND | BMI1, WEE1, WEE2 | LIG1 1836/4885BRD4 88/4885POLB 2718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.